Search Results - "Russano, M"

Novel drugs, familiar interactions: ciprofloxacin may increase exposure to the RET inhibitor pralsetinib by Citarella, F., Russano, M., Galletti, A., Vincenzi, B., Tonini, G., Santini, D.

Get full text

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer by Fornaro, L, Cereda, S, Aprile, G, Di Girolamo, S, Santini, D, Silvestris, N, Lonardi, S, Leone, F, Milella, M, Vivaldi, C, Belli, C, Bergamo, F, Lutrino, S E, Filippi, R, Russano, M, Vaccaro, V, Brunetti, A E, Rotella, V, Falcone, A, Barbera, M A, Corbelli, J, Fasola, G, Aglietta, M, Zagonel, V, Reni, M, Vasile, E, Brandi, G

“…Background: The role of second-line chemotherapy (CT) is not established in advanced biliary tract cancer (aBTC). We investigated the outcome of aBTC patients…”
Get full text

Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? by Annibali, O., Petrucci, M.T., Santini, D., Bongarzoni, V., Russano, M., Pisani, F., Venditti, O., Pantano, F., Rago, A., Siniscalchi, A., Cerchiara, E., Franceschini, L., De Rosa, L., Mariani, M., Andriani, S, Cudillo, L., Garcia, M., Cantonetti, M., Mohamed, S., Anaclerico, B., Caravita, T., Stocchi, F., Cimino, G., Gumenyuk, S., Vozella, F., Avvisati, G.

“…•Plasma ALP could be used as a discriminating marker in presence of bone lesions in solid tumor or MM.•Multiple Myeloma, ALP values were mainly in the range of…”
Get full text

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes by Cortellini, A., Leonetti, A., Catino, A., Pizzutillo, P., Ricciuti, B., De Giglio, A., Chiari, R., Bordi, P., Santini, D., Giusti, R., De Tursi, M., Brocco, D., Zoratto, F., Rastelli, F., Citarella, F., Russano, M., Filetti, M., Marchetti, P., Berardi, R., Torniai, M., Cortinovis, D., Sala, E., Maggioni, C., Follador, A., Macerelli, M., Nigro, O., Tuzi, A., Iacono, D., Migliorino, M. R., Banna, G., Porzio, G., Cannita, K., Ferrara, M. G., Bria, E., Galetta, D., Ficorella, C., Tiseo, M.

“…Background In most cases, T790M EGFR -positive NSCLC patients receiving osimertinib developed “non-drugable” progression, as the patients with common EGFR…”
Get full text

Biliary tract carcinoma and chronic viral hepatitis in Italy: the GICO (Gruppo Italiano COlangiocarcinoma) experience by Filippi, R., Frega, G., Vivaldi, C., Casadei Gardini, A., Aprile, G., Silvestris, N., Satolli, M.A., Faloppi, L., Santini, D., Lutrino, E.S., Vasile, E., Valgiusti, M., Basile, D., Brunetti, O., Spadi, R., Russano, M., Scartozzi, M., Cagnazzo, C., Brandi, G., Leone, F.

Get full text

Prognostic factors in unresectable biliary tract cancer: a GICO (Gruppo Italiano COlangiocarcinoma) retrospective analysis by Leone, F., Filippi, R., Palloni, A., Fornaro, L., Casadei Gardini, A., Aprile, G., Silvestris, N., Satolli, M.A., Faloppi, L., Daniele, S., Lutrino, E.S., Vivaldi, C., Frassineti, G.L., Garattini, S.K., Brunetti, O., Russano, M., Scartozzi, M., Cagnazzo, C., Aglietta, M., Giovanni, B.

Get full text

Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) by Pizzutilo, E.G., Agostara, A.G., Oresti, S., Signorelli, D., Stabile, S., Lauricella, C., Motta, V., Amatu, A., Ruggieri, L., Brambilla, M., Occhipinti, M., Proto, C., Giusti, R., Filetti, M., Genova, C., Barletta, G., Gelsomino, F., Bennati, C., Siringo, M., Di Fazio, G.R., Russano, M., Montrone, M., Gariazzo, E., Roca, E., Bordi, P., Delmonte, A., Scimone, A., Belluomini, L., Mazzoni, F., Carta, A., Pelizzari, G., Viscardi, G., Morgillo, F., Gelibter, A., Gori, S., Berardi, R., Cortinovis, D., Ardizzoni, A., Veronese, S.M., Sartore-Bianchi, A., Giannetta, L.G., Cerea, G., Siena, S.

“…Osimertinib represents the standard of care for the treatment of advanced non-small-cell lung cancer (NSCLC) harboring classical epidermal growth factor…”
Get full text

2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts) by Giordano, G, De Vita, F, Melisi, D, Vaccaro, V, Zaniboni, A, Zagonel, V, Vasile, E, Passardi, A, Leo, L, Ventriglia, J, Marciano, R, Russano, M, Conca, R, Andreozzi, F, Lucchini, E, Musettini, G, Bertocchi, P, Bergamo, F, Milella, M, Febbraro, A

Get full text

Bone metastases in biliary cancers: A multicenter retrospective survey by Santini, D, Brandi, G, Aprile, G, Russano, M, Cereda, S, Leone, F, Lonardi, S, Fornaro, L, Scartozzi, M, Silvestris, N, Barni, S, Pantano, F, Vincenzi, B, Palloni, A, Frega, G, Casagrande, M, Ferrari, L, Dadduzio, V, Intini, R, Filippi, R, Vasile, E, Vivaldi, C, Faloppi, L, Brunetti, O, Reni, M, Aglietta, M, Tonini, G

“…•Natural history of biliary cancers metastatic to bone•The role of skeletal events in patients with biliary cancer•Biliary cancer and bone metastases: role of…”
Get full text

Alkaline Phosphatase (ALP) Levels in Multiple Myeloma (MM) And Cancer With Bone Lesions : Is There any Difference? by Annibali, O, Petrucci, M.T, Santini, D, Mariani, M, Pisani, F, Bongarzoni, V, Venditti, O, Rago, A, Cerchiara, E, Fiorini, A, Franceschini, L, Vallone, M.L, Felici, S, Russano, M, Pantano, F, Avvisati, G

Get full text

Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes by Spinozzi, F., Russano, A. M., Piattoni, S., Agea, E., Bistoni, O., De Benedictis, D., De Benedictis, F. M.

“…Summary Background Montelukast (MNT), a cysteinyl‐leukotriene receptor (Cys‐LTR) antagonist, has anti‐inflammatory activity in the treatment of allergic…”
Get full text

Influenza viruses and cross-reactivity in healthy adults: Humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus by Iorio, Anna M, Bistoni, Onelia, Galdiero, Massimiliano, Lepri, Enrica, Camilloni, Barbara, Russano, Anna M, Neri, Mariella, Basileo, Michela, Spinozzi, Fabrizio

“…Highlights ► Humoral and cellular immune responses after seasonal 2007/2008 influenza vaccination. ► Significant homologous humoral and cellular immunity…”
Get full text

Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d-restricted γδ T cells by Russano, Anna M., Agea, Elisabetta, Corazzi, Lanfranco, Postle, Antyony D., De Libero, Gennaro, Porcelli, Steven, de Benedictis, Fernando M., Spinozzi, Fabrizio

“…Evidences from mice and human beings indicate that γδ T cells could be relevant in recognition of stress-induced self and/or yet unidentified inhaled foreign…”
Get full text

Biochemical and immunological characterization of pollen-derived beta-galactosidase reveals a new cross-reactive class of allergens among Mediterranean trees by Bistoni, Onelia, Emiliani, Carla, Agea, Elisabetta, Russano, Anna M, Mencarelli, Simona, Orlacchio, Aldo, Spinozzi, Fabrizio

“…The most potent allergens in the Spermatophytae family exhibit significant homology with enzymes. Some of these are though to be involved in pectin metabolism,…”
Get more information

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients by Cortellini, Alessio, Chiari, Rita, Ricciuti, Biagio, Metro, Giulio, Perrone, Fabiana, Tiseo, Marcello, Bersanelli, Melissa, Bordi, Paola, Santini, Daniele, Giusti, Raffaele, Grassadonia, Antonino, Di Marino, Pietro, Tinari, Nicola, De Tursi, Michele, Zoratto, Federica, Veltri, Enzo, Malorgio, Francesco, Garufi, Carlo, Russano, Marco, Anesi, Cecilia, Zeppola, Tea, Filetti, Marco, Marchetti, Paolo, Berardi, Rossana, Rinaldi, Silvia, Tudini, Marianna, Silva, Rosa Rita, Pireddu, Annagrazia, Atzori, Francesco, Iacono, Daniela, Migliorino, Maria Rita, Porzio, Giampiero, Cannita, Katia, Ficorella, Corrado, Buti, Sebastiano

“…Immune-related adverse events (irAEs) developed during immunotherapy with anti-PD-1 agents, could be a predictive surrogate marker of clinical benefit in…”
Get full text

996P Activity of OsimeRTInib in NSCLC with UNcommon EGFR Mutations: Retrospective observational multicenter study (ARTICUNO) by Pizzutilo, E.G., Cerea, G., Oresti, S., Agostara, A.G., Signorelli, D., Stabile, S., Lauricella, C., Brambilla, M., Mazzeo, L., Giusti, R., Montrone, M., Russano, M., Bennati, C., Russo, A., Viscardi, G., Roca, E., Gelibter, A.J., Cortinovis, D.L., Sartore Bianchi, A., Siena, S.

Get full text

1124P Pralsetinib in RET fusion-positive non-small cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP) by Passaro, A., Lo Russo, G., Passiglia, F., D'Arcangelo, M., Sbrana, A., Russano, M., Bonanno, L., Giusti, R., Metro, G., Bertolini, F., Grisanti, S., Carta, A., Cecere, F.L., Montrone, M., Massa, G., Attili, I., de Marinis, F.

Get full text

10P Family history of cancer correlates with improved outcome from immunotherapy in NSCLC independent of somatic DNA damage response gene status by Cortellini, A., Filetti, M., Citarella, F., Giusti, R., Russano, M., Grossi, F., Gelibter, A.J., Pecci, F., De Tursi, M., Macerelli, M., Nigro, O., Ferrara, M.G., Buti, S., Mazzoni, F., Cantini, L., Migliorino, M.R., Addeo, A., Adamo, V., Russo, A., Pinato, D.J.

Get full text

Complementary roles for lipid and protein allergens in triggering innate and adaptive immune systems by Russano, A.M, Agea, E, Casciari, C, de Benedictis, F.M, Spinozzi, F

“…Recent advances in allergy research mostly focussed on two major headings: improving protein allergen purification, which is aimed towards a better…”
Get full text

96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens by Vendittelli, A., Fiorenti, M., Mingo, E.C., Cascetta, P., La Cava, G., Santo, V., Brunetti, L., Di Chirico, A., Di Fazio, G.R., Fioroni, I., Citarella, F., Tonini, G., Vincenzi, B., Russano, M., Cortellini, A.

Get full text